Nattopharma ASA (NATTO):企業の財務・戦略的SWOT分析

◆英語タイトル:Nattopharma ASA (NATTO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14861
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nattopharma ASA (Nattopharma) is a pharmaceutical company that develops and sells vitamin K2 for health care industries. The company’s MenaQ7, a vitamin K2 as menaquinone-7 for bone and cardiovascular health and children’s health. Its MenaQ7 varieties are suitable for vegans and vegetarians, free from gluten, dairy, and other known allergens. Nattopharma develops products for supplement, health care and functional food markets. The company provides services such as marketing and sales support, clinical chemistry testing, and contract manufacturing services. It collaborates with academic institutions and research facilities for its research activities. The company has presence throughout Norway. Nattopharma is headquartered in Oslo, Norway.

Nattopharma ASA Key Recent Developments

Feb 26,2019: Vitamin K2 vs Vitamin K1 paper published in International Journal of Molecular Sciences
Feb 13,2019: NattoPharma: Strong growth and positive result
Jan 15,2019: Kaydence Pharma – Successful completion of Pre-IND meeting with FDA
Nov 19,2018: NattoPharma market update
Aug 22,2018: Nattopharma apply for delisting from NASDAQ First North

This comprehensive SWOT profile of Nattopharma ASA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nattopharma ASA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Nattopharma ASA – Key Information
Nattopharma ASA – Overview
Nattopharma ASA – Key Employees
Nattopharma ASA – Key Employee Biographies
Nattopharma ASA – Key Operational Heads
Nattopharma ASA – Major Products and Services
Nattopharma ASA – History
Nattopharma ASA – Company Statement
Nattopharma ASA – Locations And Subsidiaries
Nattopharma ASA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Nattopharma ASA – Business Description
Nattopharma ASA – Corporate Strategy
Nattopharma ASA – SWOT Analysis
SWOT Analysis – Overview
Nattopharma ASA – Strengths
Nattopharma ASA – Weaknesses
Nattopharma ASA – Opportunities
Nattopharma ASA – Threats
Nattopharma ASA – Key Competitors

Section 3 – Company Financial Performance Charts

Nattopharma ASA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Nattopharma ASA, Key Information
Nattopharma ASA, Key Ratios
Nattopharma ASA, Share Data
Nattopharma ASA, Major Products and Services
Nattopharma ASA, History
Nattopharma ASA, Key Employees
Nattopharma ASA, Key Employee Biographies
Nattopharma ASA, Key Operational Heads
Nattopharma ASA, Other Locations
Nattopharma ASA, Subsidiaries
Nattopharma ASA, Key Manufacturing facilities
Nattopharma ASA, Key Competitors
Nattopharma ASA, SWOT Analysis
Nattopharma ASA, Ratios based on current share price
Nattopharma ASA, Annual Ratios
Nattopharma ASA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Nattopharma ASA, Performance Chart
Nattopharma ASA, Ratio Charts

★海外企業調査レポート[Nattopharma ASA (NATTO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Bank Danamon Indonesia Tbk (BDMN):企業の財務・戦略的SWOT分析
    PT Bank Danamon Indonesia Tbk (BDMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mangalore Chemicals & Fertilizers Ltd (MANGCHEFER):企業の財務・戦略的SWOT分析
    Summary Mangalore Chemicals & Fertilizers Ltd (MCFL), a subsidiary of Zuari Fertilisers and Chemicals Ltd, is a chemical company that manufactures and markets fertilizers, plant nutrition products, and plant protection chemicals. The company offers urea, di-ammonium phosphate, granulated fertilizers …
  • Cox & Kings Limited:企業の戦略・SWOT・財務分析
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …
  • Pacific Gas and Electric Co-石油・ガス分野:企業M&A・提携分析
    Summary Pacific Gas and Electric Company (PGEC), a subsidiary of PG&E Corporation, is an energy utility, offering electricity and natural gas to its customers. The company carries out generation, transmission and distribution of electricity. PGEC serves residential, commercial, industrial and agricu …
  • Lenovo Group Limited:企業の戦略・SWOT・財務分析
    Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report Summary Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oxurion NV (THR):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreo …
  • Scholastic Corporation:企業の戦略・SWOT・財務情報
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Antitope Ltd:企業のM&A・事業提携・投資動向
    Antitope Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Antitope Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Polarcus Ltd (PLCS):企業の財務・戦略的SWOT分析
    Summary Polarcus Ltd (Polarcus) is a marine geophysical company that provides towed streamer data acquisition and imaging services. The company provides marine acquisition services such as vessel specifications, increasing efficiency, managing emissions to air, managing emissions to sea, polar code …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • CiMaas BV:製薬・医療:M&Aディール及び事業提携情報
    Summary CiMaas BV (CiMaas) develops cellular immunotherapies (vaccines) for the treatment of cancer. Its pipeline cellular therapeutic products include CIM101, a dendritic cell vaccine being developed using its proprietary maturation technology for the treatment of lung cancer; and CIM201, a haploid …
  • Envestnet, Inc.:企業のM&A・事業提携・投資動向
    Envestnet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Envestnet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Eddie Stobart Logistics plc:企業の戦略・SWOT・財務情報
    Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • General Motors Company:企業の戦略・SWOT・財務情報
    General Motors Company - Strategy, SWOT and Corporate Finance Report Summary General Motors Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆